|
Session 106
Poster Abstracts
Resistance Associated with ART for PMTCT
Monday, 1-4 pm
Room: Hall A |
631
 |
Intrapartum Tenofovir and Emtricitabine Reduces Development of Low-level NNRTI Resistance following Ingestion of Single-dose Nevirapine for Perinatal HIV Prevention
Benjamin Chi*1, L Frenkel2, G Aldrovandi3, N Chintu1, R Cantrell1, F Mbewe1, G Ellis2, E Stringer1, K Nakamura3, and J Stringer1
1Ctr for Infectious Disease Res in Zambia, Lusaka; 2Univ of Washington, Seatlle, US; and 3Univ of Southern California, Los Angeles, US |
632
|
Emergence and Fading of Nevirapine Resistance after First versus Repeated Use of Single-dose Nevirapine for Prevention of Mother-to-Child HIV Transmission: Women and Infants in the Repeat Pregnancy Study in Uganda
Susan Eshleman*1, T Flys1, M McConnell2, F Matovu3, J Church1, D Bagenda3, P Bakaki4, M Thigpen2, C Eure2, and M Fowler1
1Johns Hopkins Univ Sch of Med, Baltimore, MD, US; 2CDC, Atlanta, GA, US; 3Makerere Univ Johns Hopkins Univ Res Collaboration, Kampala, Uganda; and 4Case Western Reserve Univ, Cleveland, OH, US |
633
|
Dynamics of Nevirapine-resistant HIV-1 following Single-dose NVP Assessed in Plasma and Cells by Consensus Sequencing and Oligonucleotide Ligation Assay
C Kress1, Thor Wagner*1,2, N Ngo-Giang-Huong3,4, N Luekamlung5, M Techapornroong6, S Banchongkit7, S Tunsuphasawasdikul8, G Jourdain3,4, M Lallemant3,4, L Frenkel1,2, and Perinatal HIV Prevention Trial
1Univ of Washington, Seattle, US; 2Children`s Hosp and Regional Med Ctr, Seattle, WA, US; 3Inst for Res and Devt, Paris, France and Chang Mai, Thailand; 4Harvard Sch of Publ Hlth, Boston, MA, US; 5Lamphun Hosp, Thailand; 6Prapokklao Hosp, Chantaburi, Thailand; 7Rayong Hospi, Thailand; and 8Buddhachinaraj Hosp, Pitsanuloke, Thailand |
634
|
Identification of Nevirapine-resistant HIV-1 in the Latent Reservoir following Single-dose Nevirapine
Megan Wind-Rotolo*1, C Durand1, L Cranmer1, A Reid1, J Siliciano1, M Doherty1, N Martinson1,2, S Eshleman1, T Quinn1, and R Siliciano1
1Johns Hopkins Univ, Baltimore, MD, US and 2Univ of Witwatersrand, Johannesburg, South Africa |
635a
|
Frequent Emergence of Lamivudine and NNRTI Drug Resistance during Pregnancy-limited ART in the US
Roger Paredes*1,2, I Cheng3, D Kuritzkes1, R Tuomala1, and Women and Infants Study Group (WITS)
1Brigham and Women`s Hosp, Harvard Med Sch, Boston, MA, US; 2Fndns irsiCaixa and Lluita contra la SIDA, Univ Autonoma de Barcelona, Catalonia, Spain; and 3Clinical Trials & Surveys Corp, Baltimore, MD, US |
635b
|
Analysis of NVP Resistance in Ugandan Infants Who Were HIV-infected despite Receiving Single-dose Nevirapine vs Single-dose NVP Plus up to 6 Weeks of Daily NVP to Prevent HIV Vertical Transmission
Jessica Church*1, S Omer2, L Guay1, W Huang3, P Musoke4, F Mmiro5, J Jackson1, and S Eshleman1
1Johns Hopkins Univ Sch of Med, Baltimore, MD, US; 2Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 3Monogram Biosci, South San Francisco, CA, US; 4Makerere Univ, Kampala, Uganda; and 5Makerere Univ Johns Hopkins Univ Res Collaboration, Kampala, Uganda |
|
